AI assistant
Sending…
Arcutis Biotherapeutics, Inc. — Director's Dealing 2020
Nov 4, 2020
31600_dirs_2020-11-04_a24f8705-dabd-43a8-b22a-f904941f45c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Arcutis Biotherapeutics, Inc. (ARQT)
CIK: 0001787306
Period of Report: 2020-11-02
Reporting Person: Curran Terrie (Director)
More from Arcutis Biotherapeutics, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 21
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4